Results 11 to 20 of about 78,166 (208)
Application of Causal Inference to Establish Assay Effect in the Absence of a Bridging Study: A Case Study of MenACWY-CRM Conjugate Vaccine Data. [PDF]
ABSTRACT During a vaccine development program, if the assay used to measure immunological endpoints is changed, ideally, a bridging study is performed to establish the relationship between results obtained with the new and previous assay. However, this is not always feasible, and when bridging study data are absent, this can limit the ability to use ...
Adani M +4 more
europepmc +2 more sources
New serogroup of Legionella pneumophila, serogroup 8 [PDF]
A strain of Legionella pneumophila (designated Concord 3) was isolated from a postmortem lung specimen of a patient with pneumonia. Direct fluorescent-antibody and immunoelectrophoresis tests, using absorbed and unabsorbed reagents prepared to this and other strains of legionellae, indicated that the Concord 3 strain represents a new serogroup of L ...
M L, Bissett, J O, Lee, D S, Lindquist
openaire +2 more sources
Serogroup F, a new capsule serogroup of Pasteurella multocida [PDF]
Four capsule serogroups (A, B, D, and E) have been described by using passive hemagglutination tests. Serogroups A and D predominant in pasteurelloses of avian species. A new capsule serogroup of Pasteurella multocida has been isolated from turkeys in Arkansas, California, Indiana, Iowa, Missouri, New Jersey, and Virginia.
R B, Rimler, K R, Rhoades
openaire +2 more sources
Meningococcal disease serogroup C
Despite current advances in antibiotic therapy and vaccines, meningococcal disease serogroup C (MDC) remains a serious threat to global health, particularly in countries in North and Latin America, Europe, and Asia. MDC is a leading cause of morbidity, mortality, and neurological sequelae and it is a heavy economic burden.
Dickinson, Felix +2 more
openaire +6 more sources
Serogrouping of Rhodococcus equi [PDF]
AbstractThe serological relationships among 27 isolates of Rhodococcus equi selected from a total of 1,195 isolates were investigated by cross‐agglutination and absorption tests. The presence of capsular material was demonstrated in all the 27 isolates by electron microscopic observation.
M, Nakazawa +3 more
openaire +2 more sources
The elusive meningococcal meningitis serogroup: a systematic review of serogroup B epidemiology [PDF]
Invasive meningococcal disease (IMD), is a widely distributed, complex human disease affecting all age categories. The causative agent, Neisseria meningitidis, is spread through aerosol respiratory droplets. 13 different serogroups have been identified, each with varying epidemiological features including prevalence, virulence, immunogenicity ...
Racloz, V. N., Luiz, S. J.
openaire +4 more sources
Meningococcal Disease in South Africa, 1999–2002
We describe the epidemiology of invasive meningococcal disease in South Africa from August 1999 through July 2002, as reported to a laboratory-based surveillance system. Neisseria meningitidis isolates were further characterized.
Garry B. Coulson +6 more
doaj +1 more source
Slide-agglutination for rapid serological typing of Treponema hyodysenteriae [PDF]
A slide agglutination (SA) test was developed to determine the serogroup of isolates of Treponema hyodysenteriae of serogroups A to F. Rabbit antisera which are normally used for serogrouping T.
Hampson, D.J.
core +2 more sources
The expansion of hypervirulent sequence type 4821 clonal complex (CC4821) lineage Neisseria meningitidis bacteria has led to a shift in meningococcal disease epidemiology in China, from serogroup A (MenA) to MenC.
Qinglan Guo +8 more
doaj +1 more source
COVID-19 control measures have resulted in a decline in invasive bacterial disease caused by Neisseria meningitidis (IMD), Streptococcus pneumoniae (IPD), and Haemophilus influenzae (Hi-D).
Anneke Steens +5 more
doaj +1 more source

